WallStreetZenWallStreetZen

AnalystsDara Azar
Dara Azar's Stock Forecasts

Sectors:
Healthcare
Industries:
Biotechnology
Analyst Ranking
Top 46%
#2458 out of 5342 analysts
Average Return
+10.19%
Win Rate
60%3 out of 5
Risk vs Reward
Poor
Good

Dara Azar's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Enliven Therapeutics IncELVN
+51.79%$36.11$54.81
2026-06-09 -
2026-07-31
Strong Buy
Inhibrx Biosciences IncINBX
+22.23%$67.13$82.05
2026-04-08 -
2026-07-31
Strong Buy
Enliven Therapeutics IncELVN
+12.41%$48.76$54.81
2026-07-01 -
2026-07-31
Strong Buy

Dara Azar Analyst Color

Get additional color on Dara Azar's coverage of popular stocks

Dara Azar's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Summit Therapeutics IncSMMT
2Strong Buy$38.00+191.86%Maintains
8 days ago
Enliven Therapeutics IncELVN
2Strong Buy$80.00+45.96%Maintains
a month ago
Inhibrx Biosciences IncINBX
1Strong Buy$150.00+82.82%Initiates Coverage On
4 months ago
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.